Deep Learning for the Digital Pathologic Diagnosis of Cholangiocarcinoma and Hepatocellular Carcinoma: Evaluating the Impact of a Web-based Diagnostic Assistant
While artificial intelligence (AI) algorithms continue to rival human performance on a variety of clinical tasks, the question of how best to incorporate these algorithms into clinical workflows remains relatively unexplored. We investigated how AI can affect pathologist performance on the task of differentiating between two subtypes of primary liver cancer, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). We developed an AI diagnostic assistant using a deep learning model and evaluated its effect on the diagnostic performance of eleven pathologists with varying levels of expertise. Our deep learning model achieved an accuracy of 0.885 on an internal validation set of 26 slides and an accuracy of 0.842 on an independent test set of 80 slides. Despite having high accuracy on a hold out test set, the diagnostic assistant did not significantly improve performance across pathologists (p-value: 0.184, OR: 1.287 (95% CI 0.886, 1.871)). Model correctness was observed to significantly bias the pathologist decisions. When the model was correct, assistance significantly improved accuracy across all pathologist experience levels and for all case difficulty levels (p-value: < 0.001, OR: 4.289 (95% CI 2.360, 7.794)). When the model was incorrect, assistance significantly decreased accuracy across all 11 pathologists and for all case difficulty levels (p-value < 0.001, OR: 0.253 (95% CI 0.126, 0.507)). Our results highlight the challenges of translating AI models to the clinical setting, especially for difficult subspecialty tasks such as tumor classification. In particular, they suggest that incorrect model predictions could strongly bias an expert's diagnosis, an important factor to consider when designing medical AI-assistance systems.
Code (0)
등록된 구현이 없습니다.
Tasks
DiagnosticSimilar Papers 제목 키워드 기반
A Polarization and Radiomics Feature Fusion Network for the Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Classifying hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) is a critical step in treatment selection and prognosis evaluation for patients with liver diseases. Traditional histopathological diag…
Cancer ClassificationMedical Image AnalysisPrognosisPrimary liver cancer classification from routine tumour biopsy using weakly supervised deep learning
The diagnosis of primary liver cancers (PLCs) can be challenging, especially on biopsies and for combined hepatocellular-cholangiocarcinoma (cHCC-CCA). We automatically classified PLCs on routine-stained biopsies using a…
Cancer ClassificationClusteringDiagnosticWeakly-supervised LearningLeveraging weak complementary labels to improve semantic segmentation of hepatocellular carcinoma and cholangiocarcinoma in H&E-stained slides
In this paper, we present a deep learning segmentation approach to classify and quantify the two most prevalent primary liver cancers - hepatocellular carcinoma and intrahepatic cholangiocarcinoma - from hematoxylin and …
DiagnosticSegmentationSemantic Segmentationwhole slide imagesEdge-competing Pathological Liver Vessel Segmentation with Limited Labels
The microvascular invasion (MVI) is a major prognostic factor in hepatocellular carcinoma, which is one of the malignant tumors with the highest mortality rate. The diagnosis of MVI needs discovering the vessels that con…
Segmentationwhole slide imagesA transductive few-shot learning approach for classification of digital histopathological slides from liver cancer
This paper presents a new approach for classifying 2D histopathology patches using few-shot learning. The method is designed to tackle a significant challenge in histopathology, which is the limited availability of label…
Few-Shot LearningTransductive Learning